| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.1 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | -0.061 | 0.1 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.1 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.064 | 0.1 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.077 | 0.1 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | -0.061 | 0.1 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |